Rate of Transfusion for Random Donor Platelets (RDP)

Standard Transfusion Rate

Random donor platelets should be transfused over 30 minutes to 1 hour per unit, with a typical adult dose of 4-6 units of pooled random donor platelets transfused over approximately 2-4 hours total, as recommended by the American Society of Clinical Oncology 1
Each unit of random donor platelet concentrate should be infused as rapidly as tolerated by the patient, typically over 30-60 minutes per unit, according to the American Society of Clinical Oncology 1
Random donor platelets contain approximately 7.5 × 10^10 platelets per unit and should increase the platelet count by 5-10 × 10^9/L per unit in a 70 kg recipient, as reported by the Society of Critical Care Medicine 2

The interval between prophylactic transfusions in patients with acute leukemia is typically every 2-4 days, which can usually be accomplished with 4-6 units of pooled concentrates per transfusion in average-sized adults, as suggested by the American Society of Clinical Oncology 1
For therapeutic transfusions (treating active bleeding), a pool of 4-8 platelet concentrates is usually sufficient to provide hemostasis in a thrombocytopenic, bleeding patient, according to the Society of Critical Care Medicine 2

Random donor platelets can be used interchangeably with single-donor apheresis platelets, with one apheresis unit containing approximately 3-6 × 10^11 platelets (equivalent to 4-8 random donor units depending on local collection practices), as reported by the Society of Critical Care Medicine 2

Transfusion rate may need to be slowed in patients with cardiac compromise or volume overload concerns, though the evidence does not specify exact rates for these situations, as noted by the American Society of Clinical Oncology 1
Leukoreduced blood products should be used to reduce alloimmunization, febrile reactions, and CMV transmission, as recommended by the American Society of Clinical Oncology 3
The decision about transfusion rate should consider the clinical urgency—patients with active major bleeding may require more rapid infusion compared to prophylactic transfusions, according to the American Society of Clinical Oncology 1